Co-Authors
This is a "connection" page, showing publications co-authored by Amir Butt and Yuko Mishima.
Connection Strength
1.808
-
In vitro procoagulant effects of Gla-domainless factor Xa in factor XI-deficient and factor IX-deficient plasma. Thromb Res. 2025 Mar; 247:109286.
Score: 0.249
-
Andexanet-induced Heparin Resistance in Cardiac Surgery - A Rapid Review of Case Reports and Series. J Thromb Haemost. 2025 Feb 05.
Score: 0.249
-
Fibrinogen Replacement in Neonatal Cardiac Surgery: Methodological Challenges. Anesth Analg. 2025 Feb 04.
Score: 0.249
-
Elucidation of fibrinolysis in pregnant women. One size does not fit all - Letter in response to "Variability of fibrinolytic activity in pregnant patients exposed to tissue plasminogen activator: An in vitro study utilizing rotational thromboelastometry". Int J Obstet Anesth. 2024 Sep 16; 104269.
Score: 0.242
-
Heparin Resistance after Andexanet Alfa - Calling on Argatroban and Nafamostat for Rescue? J Cardiothorac Vasc Anesth. 2024 May 22.
Score: 0.237
-
Antithrombin supplementation attenuates heparin resistance in plasma spiked with Gla-domainless factor Xa S195A in?vitro. Br J Anaesth. 2024 Apr 08.
Score: 0.235
-
"Women with severe postpartum hemorrhage have a decreased endogenous thrombin potential before delivery": Comment from Mishima et?al. J Thromb Haemost. 2024 Mar; 22(3):877-878.
Score: 0.233
-
Evaluation of Thrombin and Plasmin Generation Velocity Ratios during Progressive Plasma Dilution. Anesth Analg. 2024 Aug 01; 139(2):449-451.
Score: 0.058
-
In vitro effects of Gla-domainless factor Xa analog on procoagulant and fibrinolytic pathways in apixaban-treated plasma and whole blood. Thromb Res. 2023 Oct; 230:119-125.
Score: 0.056